Molecular dynamic simulations of oxidized skin lipid bilayer and permeability of reactive oxygen species.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
14 03 2019
Historique:
received: 10 08 2018
accepted: 26 02 2019
entrez: 16 3 2019
pubmed: 16 3 2019
medline: 6 10 2020
Statut: epublish

Résumé

Lipid peroxidation by reactive oxygen species (ROS) during oxidative stress is non-enzymatic damage that affects the integrity of biological membrane, and alters the fluidity and permeability. We conducted molecular dynamic simulation studies to evaluate the structural properties of the bilayer after lipid peroxidation and to measure the permeability of distinct ROS. The oxidized membrane contains free fatty acid, ceramide, cholesterol, and 5α-hydroperoxycholesterol (5α-CH). The result of unconstrained molecular dynamic simulations revealed that lipid peroxidation causes area-per-lipid of the bilayer to increase and bilayer thickness to decrease. The simulations also revealed that the oxidized group of 5α-CH (-OOH) moves towards the aqueous layer and its backbone tilts causing lateral expansion of the bilayer membrane. These changes are detrimental to structural and functional properties of the membrane. The measured free energy profile for different ROS (H

Identifiants

pubmed: 30872693
doi: 10.1038/s41598-019-40913-y
pii: 10.1038/s41598-019-40913-y
pmc: PMC6418262
doi:

Substances chimiques

Ceramides 0
Fatty Acids, Nonesterified 0
Lipid Bilayers 0
Reactive Oxygen Species 0
Cholesterol 97C5T2UQ7J

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4496

Références

Biophys J. 2002 Oct;83(4):1842-53
pubmed: 12324406
J Phys Chem B. 2010 Dec 2;114(47):15642-9
pubmed: 21053974
Chem Phys Lipids. 1987 Jul-Sep;44(2-4):175-89
pubmed: 3311416
J Invest Dermatol. 1979 Jul;73(1):123-5
pubmed: 36435
Crit Rev Ther Drug Carrier Syst. 1987;3(2):95-122
pubmed: 3542246
J Phys Chem B. 2016 Sep 1;120(34):8987-96
pubmed: 27518707
Biophys J. 2003 Apr;84(4):2192-206
pubmed: 12668428
J Am Acad Dermatol. 2003 Mar;48(3):425-9
pubmed: 12637924
Front Pharmacol. 2018 Jun 27;9:644
pubmed: 29997501
J Comput Chem. 2005 Dec;26(16):1701-18
pubmed: 16211538
CA Cancer J Clin. 2003 Jan-Feb;53(1):5-26
pubmed: 12568441
Biochim Biophys Acta Gen Subj. 2017 Apr;1861(4):839-847
pubmed: 28137619
Biochim Biophys Acta. 2012 Oct;1818(10):2388-402
pubmed: 22634274
J Chem Theory Comput. 2008 Mar;4(3):435-47
pubmed: 26620784
Biochim Biophys Acta. 1984;738(4):251-61
pubmed: 6097299
Mutat Res. 2005 Apr 1;571(1-2):153-73
pubmed: 15748645
J Chem Inf Model. 2013 Nov 25;53(11):2908-25
pubmed: 24175728
Free Radic Biol Med. 2009 Sep 1;47(5):469-84
pubmed: 19500666
Bioinformatics. 2013 Apr 1;29(7):845-54
pubmed: 23407358
Biol Chem. 1997 Nov;378(11):1299-305
pubmed: 9426190
Biophys J. 2009 Oct 7;97(7):1941-51
pubmed: 19804725
Ann N Y Acad Sci. 1992 Nov 21;663:158-66
pubmed: 1482049
J Comput Chem. 2009 Oct;30(13):2157-64
pubmed: 19229944
Langmuir. 2010 May 4;26(9):6140-4
pubmed: 20387820
Nat Rev Cancer. 2004 Jan;4(1):23-35
pubmed: 14681688
Biophys J. 2007 Dec 15;93(12):4225-36
pubmed: 17766354
Biophys J. 1997 May;72(5):2002-13
pubmed: 9129804
Chem Phys Lipids. 2009 Jan;157(1):1-11
pubmed: 18977338
Arch Dermatol Res. 2001 Apr;293(4):191-9
pubmed: 11380152
J Lipid Res. 2008 Feb;49(2):271-81
pubmed: 17975220
Biochim Biophys Acta. 2001 Mar 9;1511(1):156-67
pubmed: 11248214
Sci Rep. 2017 Jul 18;7(1):5761
pubmed: 28720839
Br J Dermatol. 2003 Dec;149(6):1200-6
pubmed: 14674897
Crit Rev Oncol Hematol. 2002 Mar;41(3):269-85
pubmed: 11880204
Annu Rev Biochem. 1989;58:79-110
pubmed: 2673022
J Lipid Res. 1998 Aug;39(8):1529-42
pubmed: 9717713
Biochim Biophys Acta. 2016 Sep;1858(9):2191-2198
pubmed: 27349733
Int J Cancer. 1985 Apr 15;35(4):427-33
pubmed: 3988369
Biochem Biophys Res Commun. 2014 Apr 11;446(3):702-8
pubmed: 24412245
Biochim Biophys Acta. 2014 Jan;1838(1 Pt B):438-44
pubmed: 24095673
Biochem Biophys Res Commun. 1982 Mar 30;105(2):546-52
pubmed: 6284156
J Invest Dermatol. 1999 Jan;112(1):72-7
pubmed: 9886267
Biochim Biophys Acta. 1982 Jun 14;688(2):495-504
pubmed: 7104337
Biomed Res Int. 2014;2014:761264
pubmed: 24587990
Photochem Photobiol. 2010 Jul-Aug;86(4):747-51
pubmed: 20408976
Biophys J. 2004 Aug;87(2):1076-91
pubmed: 15298912
J Chem Inf Model. 2017 Aug 28;57(8):2027-2034
pubmed: 28718641
Biochemistry. 1992 Nov 10;31(44):10901-7
pubmed: 1329957
Sci Rep. 2018 Sep 5;8(1):13271
pubmed: 30185881
Annu Rev Cell Biol. 1989;5:247-75
pubmed: 2688705
Pharmacogn Rev. 2010 Jul;4(8):118-26
pubmed: 22228951

Auteurs

Dharmendra Kumar Yadav (DK)

Gachon Institute of Pharmaceutical Science & Department of Pharmacy, College of Pharmacy, Gachon University, Incheon, 406-799, South Korea. dharmendra30oct@gmail.com.

Surendra Kumar (S)

Gachon Institute of Pharmaceutical Science & Department of Pharmacy, College of Pharmacy, Gachon University, Incheon, 406-799, South Korea.

Eun-Ha Choi (EH)

Plasma Bioscience Research Center/PDP Research Center, Kwangwoon University, Nowon-Gu, Seoul, 139-791, Korea.

Sandeep Chaudhary (S)

Laboratory of Organic and Medicinal Chemistry, Department of Chemistry, Malaviya National Institute of Technology, Jaipur, 302017, India.

Mi-Hyun Kim (MH)

Gachon Institute of Pharmaceutical Science & Department of Pharmacy, College of Pharmacy, Gachon University, Incheon, 406-799, South Korea. kmh0515@gachon.ac.kr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH